Skip to main content
Premium Trial:

Request an Annual Quote

Society to Scientists: We'd Like a Little Time to Think About It

New York Times covers the increasing ethics debate around advances such as nanotechnology, which in the public eye isn't necessarily as promising as it might be to those in the scientific field. Long-term consequences of such powerful technology could be detrimental, as the argument goes. According to the article, some scientists are calling for the kind of meetings and ethical debates that ensued in the mid-70s "when the immense power of [the] emerging knowledge of gene-splicing or recombinant DNA began to dawn on [the research community]."


The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.